全文获取类型
| 收费全文 | 6554篇 |
| 免费 | 431篇 |
| 国内免费 | 16篇 |
专业分类
| 耳鼻咽喉 | 69篇 |
| 儿科学 | 277篇 |
| 妇产科学 | 73篇 |
| 基础医学 | 711篇 |
| 口腔科学 | 140篇 |
| 临床医学 | 463篇 |
| 内科学 | 1432篇 |
| 皮肤病学 | 162篇 |
| 神经病学 | 501篇 |
| 特种医学 | 185篇 |
| 外科学 | 1261篇 |
| 综合类 | 145篇 |
| 一般理论 | 1篇 |
| 预防医学 | 344篇 |
| 眼科学 | 193篇 |
| 药学 | 581篇 |
| 中国医学 | 18篇 |
| 肿瘤学 | 445篇 |
出版年
| 2023年 | 56篇 |
| 2022年 | 106篇 |
| 2021年 | 276篇 |
| 2020年 | 116篇 |
| 2019年 | 198篇 |
| 2018年 | 229篇 |
| 2017年 | 176篇 |
| 2016年 | 201篇 |
| 2015年 | 205篇 |
| 2014年 | 262篇 |
| 2013年 | 359篇 |
| 2012年 | 470篇 |
| 2011年 | 490篇 |
| 2010年 | 299篇 |
| 2009年 | 244篇 |
| 2008年 | 330篇 |
| 2007年 | 362篇 |
| 2006年 | 276篇 |
| 2005年 | 317篇 |
| 2004年 | 247篇 |
| 2003年 | 240篇 |
| 2002年 | 211篇 |
| 2001年 | 93篇 |
| 2000年 | 93篇 |
| 1999年 | 94篇 |
| 1998年 | 46篇 |
| 1997年 | 22篇 |
| 1996年 | 28篇 |
| 1995年 | 26篇 |
| 1994年 | 25篇 |
| 1993年 | 25篇 |
| 1992年 | 64篇 |
| 1991年 | 55篇 |
| 1990年 | 29篇 |
| 1989年 | 45篇 |
| 1988年 | 42篇 |
| 1987年 | 42篇 |
| 1986年 | 34篇 |
| 1985年 | 32篇 |
| 1984年 | 24篇 |
| 1983年 | 32篇 |
| 1982年 | 28篇 |
| 1979年 | 20篇 |
| 1976年 | 25篇 |
| 1975年 | 28篇 |
| 1974年 | 27篇 |
| 1973年 | 23篇 |
| 1971年 | 27篇 |
| 1970年 | 31篇 |
| 1969年 | 25篇 |
排序方式： 共有7001条查询结果，搜索用时 15 毫秒
1.
Tofacitinib is an immunosuppressive and disease-modifying therapy in rheumatoid arthritis. It may result in many infections flaring up. It is important to take precautions of all kinds (cardiovascular, malignancy, infections etc.) before starting tofacitinib. In this article, we have highlighted important steps where we need to take precautions before starting tofacitinib. 相似文献
2.
3.
4.
5.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献6.
7.
Roberto V.P. Ribeiro Mitesh V. Badiwala Danny Ramzy Laura C. Tumiati Vivek Rao 《The Journal of thoracic and cardiovascular surgery》2019,157(2):615-625.e1
Objective
Hypertonic saline (HTS) has potent immune and vascular effects. We assessed recipient pretreatment with HTS on allograft function in a porcine model of heart transplantation and hypothesized that HTS infusion would limit endothelial and left ventricular (LV) dysfunction following transplantation.Methods
Heart transplants were performed after 6 hours of cold ischemic storage. Recipient pigs were randomized to treatment with or without HTS (7.5% NaCl) before cardiopulmonary bypass (CPB). Using a myograft apparatus, coronary artery endothelial-dependent (Edep) and -independent (Eind) relaxation was assessed. LV performance was determined using pressure-volume loop analysis. Pulmonary interleukin (IL)-2, IL-6, and tumor necrosis factor (TNF)-α expression was measured.Results
Weaning from CPB and LV performance after transplantation were improved in HTS-treated animals. Successful weaning from CPB was greater in the HTS-treated hearts (8 of 8 vs 2 of 8; P < .05). Mean LV functional recovery was improved in the HTS-treated animals, as assessed by preload recruitable stroke work (65 ± 10% vs 27 ± 10%; P < .001) and end-systolic elastance (55 ± 7% vs 37 ± 4%; P < .001). Treatment with HTS resulted in improved Edep (mean maximum elastance [Emax], 56 ± 5% vs 37 ± 7%; P < .001) and Eind (mean Emax%, 77 ± 6% vs 52 ± 4%; P < .001) vasorelaxation compared with control. Pulmonary expression of IL-2, IL-6, and TNF-α increased following transplantation, whereas HTS therapy attenuated IL production (P < .001). Transplantation increased plasma TNF-α levels and LV TNF-α expression, whereas HTS prevented this up-regulation (P < .001).Conclusions
Recipient HTS pretreatment preserves allograft vasomotor and LV function, and HTS therapy limits CPB-induced injury. HTS may be a novel recipient intervention to prevent graft dysfunction. 相似文献8.
9.
Functional recovery, the goal of treatment, has long been overlooked in the assessment of effectiveness of pharmacological treatments. However, with the recent shift in paradigm, from syndromal–symptomatic recovery to functional recovery, there appears to be a new interest in the definition and evaluation of functional recovery. Since functional recovery lags symptomatic recovery, sometimes by months or years, the attainment of functional recovery will be determined by both efficacy and long-term compliance. Quetiapine, due to its efficacy in both mania and depression, and effect on cognition may lead to improved functioning in patients with bipolar disorder. 相似文献
10.
YS Nagar S Singh V Sawlani L Pal K Dimri P Lal 《Journal of Medical Imaging and Radiation Oncology》2005,49(2):160-162
A rare case of an advanced primary broad ligament carcinoma is discussed, with a review of the literature regarding its incidence, presentation and management. This patient showed a complete response to adjuvant cisplatin-based chemotherapy following panhysterectomy and is presently without any evidence of disease, 15 months after completion of her treatment. 相似文献